These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29806520)

  • 1. Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis.
    Xia X; Chen J; Xia J; Wang B; Liu H; Yang L; Wang Y; Ling Z
    J Int Med Res; 2018 Sep; 46(9):3596-3604. PubMed ID: 29806520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Malaguarnera G; Salmeri M; Mastrojeni S; Rampello L; Pennisi G; Li Volti G; Galvano F
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):199-206. PubMed ID: 19730107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Greco F; Barone G; Gargante MP; Malaguarnera M; Toscano MA
    Dig Dis Sci; 2007 Nov; 52(11):3259-65. PubMed ID: 17393330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
    Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
    Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment.
    Shi J; Li F
    Eur J Gastroenterol Hepatol; 2023 Jul; 35(7):777-781. PubMed ID: 37161982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis.
    Huang L; Yu Q; Peng H; Zhen Z
    Medicine (Baltimore); 2022 Dec; 101(51):e32335. PubMed ID: 36595801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
    Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
    Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.
    Li W; Li N; Wang R; Li Q; Wu H
    Hepatol Int; 2015 Apr; 9(2):218-23. PubMed ID: 25794550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis.
    Luo M; Hu FR; Xin RJ; Yao L; Hu SJ; Bai FH
    Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):797-807. PubMed ID: 35942803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
    Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
    Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.